北大人民医院ECMO应用经验:辅助循环“烟囱技术”可改善出血和远端肢体缺血情况

2018-05-02 xujing 中国循环杂志

北京大学人民医院廉波等研究提示,与直接插管相比,VA-ECMO辅助循环“ 烟囱技术”可改善ECMO 的插管部位出血和远端肢体缺血情况。


北京大学人民医院廉波等研究提示,与直接插管相比,VA-ECMO辅助循环“ 烟囱技术”可改善ECMO 的插管部位出血和远端肢体缺血情况。
 
本组行VA-ECMO 辅助的难治性心力衰竭(心衰)患者37例,均使用同侧股动静脉插管建立ECMO 通路。
 
21例患者接受股动脉切开直接插管,根据远端肢体缺血情况,在ECMO 循环管路上使用ARROW 双腔深静脉插管建立向远端肢体的侧支循环,16例患者接受了“烟囱技术”,即股动脉切开后,端侧吻合直径8 mm 的涤纶人工血管,然后将动脉插管插入人工血管,动脉插管尖端位于吻合口附近。
 
经股动静脉的“烟囱技术”和直接动静脉插管相比较,能够明显改善每日插管部位出血情况,减少患者用血量,较明显地改善插管远端肢体的缺血情况。
 
但“烟囱技术”涉及血管吻合,延长插管时间,而且“烟囱技术”对住院期间死亡率无影响。
 
对于需要建立ECOM 的患者,研究者建议采用以下策略:
 
(1)对于需要急救患者,可以通过直接插管的方式进行VA-ECOM 辅助,减少手术操作时间,减少组织低灌注或无灌注时间;
 
(2)对于股动脉血管无异常的患者,为减少下肢缺血并发症的发生,可以在股动静脉直接插管后选择合适的侧支循环管路,进行VAECMO辅助;
 
(3)对于股动脉偏细的患者,可以使用“烟囱技术”进行VA-ECMO 辅助;
 
(4)如果股动脉本身存在病变或狭窄,可以考虑锁骨下动脉途径进行VA-ECMO 辅助。
 
原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2003589, encodeId=ce682003589b3, content=<a href='/topic/show?id=9fc333e0363' target=_blank style='color:#2F92EE;'>#北大人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33703, encryptionId=9fc333e0363, topicName=北大人民医院)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Mon May 28 00:53:00 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914945, encodeId=ce481914945e0, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat May 19 04:53:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755634, encodeId=c3831e55634c3, content=<a href='/topic/show?id=85294906ef' target=_blank style='color:#2F92EE;'>#CMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4906, encryptionId=85294906ef, topicName=CMO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4136982125, createdName=zhangbaojun, createdTime=Tue Oct 09 20:53:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312281, encodeId=4f78312281dc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat May 05 18:00:15 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311892, encodeId=37e43118921d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri May 04 08:52:40 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311551, encodeId=db3e311551a3, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:24:54 CST 2018, time=2018-05-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2003589, encodeId=ce682003589b3, content=<a href='/topic/show?id=9fc333e0363' target=_blank style='color:#2F92EE;'>#北大人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33703, encryptionId=9fc333e0363, topicName=北大人民医院)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Mon May 28 00:53:00 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914945, encodeId=ce481914945e0, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat May 19 04:53:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755634, encodeId=c3831e55634c3, content=<a href='/topic/show?id=85294906ef' target=_blank style='color:#2F92EE;'>#CMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4906, encryptionId=85294906ef, topicName=CMO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4136982125, createdName=zhangbaojun, createdTime=Tue Oct 09 20:53:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312281, encodeId=4f78312281dc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat May 05 18:00:15 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311892, encodeId=37e43118921d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri May 04 08:52:40 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311551, encodeId=db3e311551a3, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:24:54 CST 2018, time=2018-05-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2003589, encodeId=ce682003589b3, content=<a href='/topic/show?id=9fc333e0363' target=_blank style='color:#2F92EE;'>#北大人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33703, encryptionId=9fc333e0363, topicName=北大人民医院)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Mon May 28 00:53:00 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914945, encodeId=ce481914945e0, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat May 19 04:53:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755634, encodeId=c3831e55634c3, content=<a href='/topic/show?id=85294906ef' target=_blank style='color:#2F92EE;'>#CMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4906, encryptionId=85294906ef, topicName=CMO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4136982125, createdName=zhangbaojun, createdTime=Tue Oct 09 20:53:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312281, encodeId=4f78312281dc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat May 05 18:00:15 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311892, encodeId=37e43118921d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri May 04 08:52:40 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311551, encodeId=db3e311551a3, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:24:54 CST 2018, time=2018-05-03, status=1, ipAttribution=)]
    2018-10-09 zhangbaojun
  4. [GetPortalCommentsPageByObjectIdResponse(id=2003589, encodeId=ce682003589b3, content=<a href='/topic/show?id=9fc333e0363' target=_blank style='color:#2F92EE;'>#北大人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33703, encryptionId=9fc333e0363, topicName=北大人民医院)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Mon May 28 00:53:00 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914945, encodeId=ce481914945e0, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat May 19 04:53:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755634, encodeId=c3831e55634c3, content=<a href='/topic/show?id=85294906ef' target=_blank style='color:#2F92EE;'>#CMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4906, encryptionId=85294906ef, topicName=CMO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4136982125, createdName=zhangbaojun, createdTime=Tue Oct 09 20:53:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312281, encodeId=4f78312281dc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat May 05 18:00:15 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311892, encodeId=37e43118921d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri May 04 08:52:40 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311551, encodeId=db3e311551a3, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:24:54 CST 2018, time=2018-05-03, status=1, ipAttribution=)]
    2018-05-05 yfjms

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2003589, encodeId=ce682003589b3, content=<a href='/topic/show?id=9fc333e0363' target=_blank style='color:#2F92EE;'>#北大人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33703, encryptionId=9fc333e0363, topicName=北大人民医院)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Mon May 28 00:53:00 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914945, encodeId=ce481914945e0, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat May 19 04:53:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755634, encodeId=c3831e55634c3, content=<a href='/topic/show?id=85294906ef' target=_blank style='color:#2F92EE;'>#CMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4906, encryptionId=85294906ef, topicName=CMO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4136982125, createdName=zhangbaojun, createdTime=Tue Oct 09 20:53:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312281, encodeId=4f78312281dc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat May 05 18:00:15 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311892, encodeId=37e43118921d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri May 04 08:52:40 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311551, encodeId=db3e311551a3, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:24:54 CST 2018, time=2018-05-03, status=1, ipAttribution=)]
    2018-05-04 smartxiuxiu

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2003589, encodeId=ce682003589b3, content=<a href='/topic/show?id=9fc333e0363' target=_blank style='color:#2F92EE;'>#北大人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33703, encryptionId=9fc333e0363, topicName=北大人民医院)], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160723/IMG57937A3BB59F33185.jpg, createdBy=7642322, createdName=手留余香, createdTime=Mon May 28 00:53:00 CST 2018, time=2018-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1914945, encodeId=ce481914945e0, content=<a href='/topic/show?id=e823249e392' target=_blank style='color:#2F92EE;'>#人民医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24973, encryptionId=e823249e392, topicName=人民医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Sat May 19 04:53:00 CST 2018, time=2018-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755634, encodeId=c3831e55634c3, content=<a href='/topic/show?id=85294906ef' target=_blank style='color:#2F92EE;'>#CMO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4906, encryptionId=85294906ef, topicName=CMO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e4136982125, createdName=zhangbaojun, createdTime=Tue Oct 09 20:53:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312281, encodeId=4f78312281dc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat May 05 18:00:15 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311892, encodeId=37e43118921d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Fri May 04 08:52:40 CST 2018, time=2018-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311551, encodeId=db3e311551a3, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu May 03 07:24:54 CST 2018, time=2018-05-03, status=1, ipAttribution=)]
    2018-05-03 张新亮1853311252142e2fm

    好文献.学习了

    0

相关资讯

Am J Resp Crit Care:体外膜肺氧合治疗儿童出血和血栓形成的相关因素有哪些?

由此可见,出血和血栓形成发生率在ECMO支持期间较高。实验室取样是ECMO支持期间输血的一个主要促进因素。以减少出血和血栓形成每日风险以及不同输血阈值的策略可能是未来以期改善需要这种支持疗法儿童结局的试验较好的主题。

Crit care:ARDS患者进行ECMO的死亡率预测模型比较!

体外膜肺氧合(ECMO)是挽救急性呼吸窘迫综合征(ARDS)患者生命的一种疗法,但其与并发症和花费成本相关。近期,一项发表在杂志Crit care上的研究验证了分数差异对预测死亡率和发展优化的分类模型。此项研究为推导队列研究,对108例静脉-静脉ECMO的ARDS患者(2010-2015)进行了回顾性分析,以评估对死亡率预测(受试者操作)的四个已建立的风险评分(ECMOnet评分,RESP评分,P

"我就是想让他活下来!"

导读:医生对治愈的渴望是这个职业最原始的驱动力;零的突破那种欢欣和喜悦,是为了挑战难度的技术突破,也是为了病人的新生。 我是一个ICU医生,一个工作了18年的ICU医生,做成第一例ECMO一直在我的短期计划中。 为什么这么向往做ECMO?因为它就像神奇的兵器倚天剑。处于精力体力巅峰状态的武士一定会向往有机会用它来建功立业,印证自己半生的经验和技艺。 这样繁复的操作

ECMO治疗重症儿童心肌炎:优势和争议

儿童心肌炎,虽大多数临床症状轻微预后良好,但也有少数病例起病急、病情重、死亡率高达50%以上。体外膜肺氧合(ECMO)是治疗难治性心/肺功能衰竭的有效手段。那么在治疗重症儿童心肌炎方面有哪些优势?

龙村副主委:ECMO在意外低温救治中的应用

据不完全统计,2012年英国有166人因意外低温死亡,2009年至2012年波兰有1836人由于长时间暴露在低温环境中死亡,这其中有489例(26.6%)是在医院内死亡的。早前的意外低温病例,主要是在偏远地区如雪崩,溺水等。近年来越来越多的病例出现在城市中,主要发生在酒精中毒,药物过量,精神疾病患者中。